As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: March 8, 2012
by Alzheimer’s Association
Cost to nation
In 2012, the direct costs of caring for those with Alzheimer’s or other dementias to American society will total an estimated $200 billion, including $140 billion in costs to Medicare and Medicaid.
Average per person Medicare payments for an older person with Alzheimer’s or other dementias are nearly 3 times higher than for an older person without these conditions. Medicaid payments are 19 times higher. These costs will only continue to soar in the coming years given the projected rapidly escalating prevalence of Alzheimer’s disease as the baby boomers age.
Unless something is done, the care costs of Alzheimer’s and other dementias will soar from $200 billion this year to a projected $1.1 trillion (in today’s dollars) by 2050. This dramatic rise includes a 500 percent increase in combined Medicare and Medicaid spending.
Expanding Impact of Alzheimer’s Disease and Dementia
Alzheimer’s is the sixth-leading cause of death in the country and the only cause of death among the top 10 in the United States that cannot be prevented, cured or even slowed. Based on final mortality data from 2000-2008, death rates have declined for most major diseases—heart disease (-13 percent), breast cancer (-3 percent), prostate cancer (-8 percent), stroke (-20 percent) and HIV/AIDS (-29)—while deaths from Alzheimer’s disease have risen 66 percent during the same period.
People with Alzheimer’s living alone
An estimated 800,000 individuals with Alzheimer’s (or one in seven) live alone. People with Alzheimer’s and other dementias who live alone are exposed to higher risks—including inadequate self-care, malnutrition, untreated medical conditions, falls, wandering from home unattended and accidental deaths—compared to those who do not live alone. Of those who have Alzheimer’s and live alone, up to half of them do not have an identifiable caregiver.
Memory loss and cognitive decline are commonly thought to be the earliest signs of the disorder, but a new study has found declines in glucose levels in the brain come even sooner. Even better? The same team...
by G.S. Mudur for The Telegraph Ashwagandha, a plant used for centuries in Ayurvedic medicine, cleaned out abnormal protein deposits in the brain and reversed damage and behavioural changes observed in Alzheimer’s disease when tested on mice, a team of...
by Karen Ravn for Dementia Today Alzheimers symptoms and signs are unique on each patient. Through that it sometimes will be tricky to diagnose Alzheimers disease. Several of the signs and symptoms present in Alzheimer’s disease also exist in other conditions...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.